Prostate Cancer

Our nationally and internationally known specialists offer the most up-to-date, research-backed prostate cancer treatments, including targeted ablation using cryo-ablation and high-intensity focused ultrasound, or HIFU. Our comprehensive services include precision screening, diagnosis, post-treatment rehabilitation, and integrative therapies, as well as second opinion consultations to help you better understand your testing and treatment options.

Perlmutter Cancer Center doctors share in the growing consensus among top prostate cancer specialists that many men are being overtreated for prostate cancer. We work together to identify which men are best served by aggressive treatment and those who can be treated safely with a more conservative approach. We believe in empowering you with information, so that you can actively partner in creating a personalized treatment plan that’s right for you.

Clinical Trials and Research Studies

Phase 2

INTREPId (INTermediate Risk Erection PreservatIon Trial): A Randomized Trial of Radiation Therapy and Darolutamide for Prostate Cancer

Learn More

Phase 3

Phase 3 Randomized Double-blind Trial of Pembrolizumab (MK-3475) Plus Enzalutamide Plus ADT Versus Placebo Plus Enzalutamide Plus ADT in Participants With Metastatic Hormone-Sensitive Prostate Cancer (mHSPC) (KEYNOTE-991)

Learn More

Phase 5

A Phase 1b/2 Open-Label Randomized Platform Study Evaluating the Efficacy and Safety of AB928-Based Treatment Combinations in Patients with Metastatic Castrate Resistant Prostate Cancer

Learn More

Phase 1

A Phase 1/1b Open-Label Multi-Center Study to Characterize the Safety and Tolerability of TRQ15-01 in Patients with Relapsed/Refractory Solid Tumors and Lymphomas

Learn More